← Leaderboards
Anil Kumar Ojha
University Of Pittsburgh At Pittsburgh
$4,738,622
Attributed
$5,869,044
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,869,044 · 6
By mechanism
R01$4,029,224 · 2
R21$1,839,820 · 4
Top collaborators
- Rajendra K Agrawal3 shared
- Pallavi Ghosh1 shared
- Mercedes Gonzalez-Juarrero1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Catherine L Haggerty$10,431,738
- Pallavi Ghosh$3,930,342
- J Scott Vanepps$3,068,410
- Mingui Sun$11,879,919
- Dexing Zeng$838,725
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisGrowthMycobacterialMycobacterium SmegmatisPharmaceutical PreparationsAntibioticsTuberculosis TreatmentInfectionInsightBaseChronicPathogenRegimenStructureCellsProteinsResponseZincStarvationBindingRibosomesPhenotypeDrug Resistance
Grant awards (18)
Therapeutic potential of mycobacteriophage LysB against Mycobacterium abscessus infections$689,051
R01 · FY2025 · AI · contact PI
Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria$446,664
R01 · FY2025 · AI · contact PI
Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria$454,818
R01 · FY2024 · AI · contact PI
Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria$440,628
R01 · FY2023 · AI · contact PI
Origins of zinc starvation in Mycobacterium tuberculosis during chronic infection$201,128
R21 · FY2022 · AI · contact PI
Alternative ribosomes and antibiotic tolerance in mycobacteria.$405,545
R01 · FY2021 · AI · contact PI
Origins of zinc starvation in Mycobacterium tuberculosis during chronic infection$223,662
R21 · FY2021 · AI · contact PI
Alternative ribosomes and antibiotic tolerance in mycobacteria.$399,156
R01 · FY2020 · AI · contact PI
Physiology of Mycobacterium Tuberculosis with Hibernating Ribosomes$214,140
R21 · FY2020 · AI · contact PI
Alternative ribosomes and antibiotic tolerance in mycobacteria.$403,825
R01 · FY2019 · AI · contact PI
Physiology of Mycobacterium Tuberculosis with Hibernating Ribosomes$251,879
R21 · FY2019 · AI · contact PI
Alternative ribosomes and antibiotic tolerance in mycobacteria.$400,352
R01 · FY2018 · AI · contact PI
Alternative ribosomes and antibiotic tolerance in mycobacteria.$389,185
R01 · FY2017 · AI · contact PI
Enzyme-based lysis of mycobacteria$161,268
R21 · FY2015 · AI · contact PI
Enzyme-based lysis of mycobacteria$228,750
R21 · FY2014 · AI · contact PI
Identification of factors that control Mycobacterium tuberculosis biofilm growth$142,368
R21 · FY2010 · AI · contact PI
Identification of factors that control Mycobacterium tuberculosis biofilm growth$189,375
R21 · FY2009 · AI · contact PI
Identification of factors that control Mycobacterium tuberculosis biofilm growth$227,250
R21 · FY2008 · AI · contact PI